Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease

Toth, PP; Dwyer, JP; Cannon, CP; Colhoun, HM; Rader, DJ; Upadhyay, A; Louie, MJ; Koren, A; Letierce, A; Mandel, J; Banach, M

Toth, PP (reprint author), CGH Med Ctr, 101 East Miller Rd, Sterling, IL 61081 USA.

KIDNEY INTERNATIONAL, 2018; 93 (6): 1397

Abstract

Individuals with chronic kidney disease are at increased risk of premature cardiovascular disease. Among them, many with elevated low-density lipoprot......

Full Text Link